Kevin McKernan is the Chief Scientific Officer and Founder of Medicinal Genomics. Kevin has pioneered the genomics of cannabis and hemp to build a stronger scientific environment for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics.







At CannMed 24 he will present “Understanding the Prevalence and Risks Associated with Endotoxins on Cannabis Flower”, which will include novel research he did to measure the level of endotoxins in store-bought cannabis flower. Our conversation covers:









What inspired Kevin to look into endotoxin levels on cannabis







Which microbes produce endotoxins







How endotoxins affect humans







Whether remediation techniques mask endotoxin risks







and more









Thanks to This Episode's Sponsor: Agilent Technologies.







Whether you manufacture or test cannabis, you face the challenge of delivering high-quality products, increasing sample volume, and meeting emerging regulations. Agilent offers best-in-class cannabis and hemp analysis solutions featuring robust instruments, software, services, and consumables. Their team of experts can develop, implement, and optimize methods to get you up and running quickly.







Learn more at agilent.com







Additional Resources









High levels of endotoxins in commercial cannabis flower [Pre-Print]







Total Yeast and Mold - A Comparison Study - Jini Glaros [CannMed 23 Presentation]







What Makes CannMed Unique and Why You Don’t Want to Miss It







Register for CannMed 24







Review the Podcast!







CannMed Archive